98%
921
2 minutes
20
The aim of this study was to evaluate athletic performance and training in transgender women (TW) athletes competing in running and swimming both pre and post gender affirming hormone therapy (GAHT). Using survey methods, 9 TW runners and 1 TW swimmer provided independently verified retrospective data for race times, training volume, height, body mass, and testosterone, oestrogen and haemoglobin concentrations and pre-GAHT and post-GAHT. Prospective data were collected for a further 12 months. Changes in performance and age-grade scores (AGs) for runners and FINA scores for the swimmer were calculated. For runners, pre-GAHT and post-GAHT differences in AGs were adjusted based on training differences over time. Post-GAHT, testosterone concentrations in TW (1.10 ± 0.52 nmol·L) were female typical. Average race time for the runners increased by 14.6 ± 5.6% after 31 ± 23 months (range 5-86 months) of GAHT. Changes in training were positively associated with changes in AGs (p = 0.008). Pre-GAHT and post-GAHT average AGs of the runners did not differ with or without adjustment (p = 0.304) for training differences. Average race times for the swimmer increased by 5.2 ± 2.3% and FINA score increased by 65 points after 34 months of GAHT. In our sample of TW athletes taking GAHT, longer distance events were associated with larger decrements in performance compared with shorter distance events, with exercise training helping attenuate these decrements. Event demands and exercise training may be important considerations in understanding the effects of GAHT on athletic performance in TW athletes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12350078 | PMC |
http://dx.doi.org/10.1002/ejsc.70036 | DOI Listing |
Eur J Sport Sci
September 2025
School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, UK.
The aim of this study was to evaluate athletic performance and training in transgender women (TW) athletes competing in running and swimming both pre and post gender affirming hormone therapy (GAHT). Using survey methods, 9 TW runners and 1 TW swimmer provided independently verified retrospective data for race times, training volume, height, body mass, and testosterone, oestrogen and haemoglobin concentrations and pre-GAHT and post-GAHT. Prospective data were collected for a further 12 months.
View Article and Find Full Text PDFEur Heart J Digit Health
January 2025
Department of Cardiovascular Medicine, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA.
Aims: Gender-affirming hormone therapy (GAHT) is used by some transgender individuals (TG), who comprise 1.4% of US population. However, the effects of GAHT on electrocardiogram (ECG) remain unknown.
View Article and Find Full Text PDFHealthcare (Basel)
January 2023
Institute of Mental Health, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham NG7 2TU, UK.
While positive changes in mental health have been found following gender-affirming hormone treatment (GAHT), it is unclear how pre-GAHT mental health and social support can influence treatment outcomes. To address this, a retrospective longitudinal design was used in which 137 participants completed measures of social support, anxiety, and depression prior to GAHT (T0) and a measure of life satisfaction 18 months after GAHT (T1). The data showed no significant differences in life satisfaction at T1 based on T0 caseness of anxiety or depression.
View Article and Find Full Text PDFMil Med
July 2023
Department of Adolescent Medicine, San Antonio Uniformed Services Health Education Consortium, San Antonio, TX 78234, United States.
Introduction: Transgender individuals have served openly in the U.S. Military since 2016.
View Article and Find Full Text PDF